Recombinant Human Leukemia inhibitory factor/LIF Protein
Recombinant Human Leukemia inhibitory factor/LIF Protein (RP00089-GRP)
Products
Description
Recombinant Human Leukemia inhibitory factor/LIF Protein is produced by HEK293 expression system. The target protein is expressed with sequence (Ser23-Phe202) of human LIF (Accession #NP_002300.1) fused with a 6×His tag at the C-terminus.
Specifications
| Manufacturer | Abclonal Biotechnology |
|---|---|
| Manufacturer Cat# | RP00089 |
| Bio-Activity | Measured in a cell proliferation assay using TF-1 human erythroleukemic cells. The ED50 for this effect is typically 0.1-0.3 ng/mL, corresponding to a specific activity of 3.33×106-1×107units/mg. |
| Alternate Names | LIF,CDF,DIA,HILDA,MLPLI |
| Reactivity | Human |
| Gene ID | 3976 |
| Swiss Prot | P15018 |